Codes / ICD10CM / H35.3290

H35.3290 Exudative age-related macular degeneration, unspecified eye, stage unspecified

ICD10CM code

ICD10CM

Chat with GenHealth to automate any coding or chart task.

Name of the Condition

  • Exudative Age-Related Macular Degeneration, Unspecified Eye, Stage Unspecified

Summary

Exudative age-related macular degeneration (AMD) is a chronic eye condition that causes vision loss in the central field due to damage to the retina. This type, also known as wet AMD, is characterized by the growth of abnormal blood vessels underneath the retina that leak fluid or blood, potentially leading to rapid vision loss. The stage unspecified designation indicates that the current activity level of the condition is not documented.

Causes

The precise cause of exudative AMD is not completely understood but is believed to involve a combination of genetic and environmental factors. Age is the most significant factor, along with genetic predisposition and possibly oxidative stress impacting retinal cells.

Risk Factors

  • Age (more common in those over 50)
  • Family history of AMD
  • Smoking
  • Obesity
  • Hypertension
  • High cholesterol levels
  • Light eye color

Symptoms

  • Blurred or reduced central vision
  • Distortion of straight lines
  • Difficulty recognizing faces
  • Dark, blurry areas in the center of vision

Diagnosis

Diagnosis typically involves a comprehensive eye exam, including visual acuity testing, dilated eye examination, optical coherence tomography (OCT) to visualize the retina, and fluorescein angiography to detect abnormal blood vessel growth and leakage. The stage unspecified designation may reflect incomplete documentation of the condition's activity level during evaluation.

Treatment Options

  • Anti-VEGF injections (e.g., ranibizumab, bevacizumab) to halt or reduce growth of abnormal blood vessels
  • Photodynamic therapy (PDT)
  • Laser therapy (less common due to potential damage)

Prognosis and Follow-Up

Prognosis varies depending on the stage and response to treatment. Regular follow-up with an ophthalmologist is essential to monitor disease progression and adjust treatment as needed. Vision loss may be irreversible if left untreated, but early intervention can help preserve remaining vision.

Complications

  • Permanent central vision loss
  • Difficulty with daily activities (reading, driving)
  • Increased risk of depression due to vision impairment

Lifestyle & Prevention

  • Quit smoking
  • Maintain a healthy diet rich in antioxidants (leafy greens, fish)
  • Control blood pressure and cholesterol
  • Protect eyes from UV light with sunglasses
  • Regular eye exams, especially for those over 50

When to Seek Professional Help

Seek immediate medical attention if you experience sudden changes in vision, such as blurriness, distortion, or dark spots, as these may indicate active disease progression requiring prompt treatment.

Tips for Medical Coders

Document the eye (unspecified) and stage (unspecified) as provided. Ensure clinical documentation supports the unspecified designations, as specificity may be required for accurate coding in some settings. Verify that the code aligns with the documented activity level of the choroidal neovascularization if further details become available.

Book a walkthrough

H35.3290 policy automation walkthrough

Walk through the policies, prior authorization requirements, and workflow automation opportunities connected to this code.